Results 1 to 10 of about 1,105,003 (199)

HSP70 is a chaperone for IL-33 activity in chronic airway disease. [PDF]

JCI Insight
Osorio OA, Raphael HE, Kluender CE, Hassan GF, Cohen LS, Steinberg DF, Katz-Kiriakos E, Payne MD, Luo EM, Hicks JL, Byers DE, Alexander-Brett J.   +11 more
europepmc   +1 more source

Distinct Roles for Thymic Stromal Lymphopoietin (TSLP) and IL-33 in Experimental Eosinophilic Esophagitis. [PDF]

Allergy
Dsilva A, Wagner A, Itan M, Rhone N, Avlas S, Gordon Y, Davidian N, Sharma S, Razravina E, Zan-Bar I, Parnes JR, Gorski KS, Sherrill JD, Varol C, Ziegler SF, Rothenberg ME, Munitz A.   +16 more
europepmc   +1 more source

The IL-33/ST2 Axis Is Not Required for the Profibrotic Effect of IL-33 in the Lungs. [PDF]

Am J Respir Cell Mol Biol
Atamas SP, Lockatell V, Todd NW, Luzina IG.   +3 more
europepmc   +1 more source

Senescence‑associated IL‑33 secretion undermines sorafenib efficacy in hepatocellular carcinoma via immune evasion. [PDF]

Oncol Rep
Lin YX, Liu H, Liao WC, Wang YC, Zhang BC, Wan SW, Chen CC, Chang CP.   +7 more
europepmc   +1 more source

Does IL-31 level have more significance in chronic urticaria, when compared with IL-33 level? [PDF]

Postepy Dermatol Alergol
Özden G, Acık DY, Tekin A, Bankir M, Cevirme L, Solak Y.   +5 more
europepmc   +1 more source

Therapeutic effects of IL-33/ST-2 pathway inhibition combined with albendazole on hepatic fibrosis and immune regulation in alveolar echinococcosis: in vivo and in vitro evidence. [PDF]

Parasit Vectors
Cheng SL, Ma XM, Wu BJ, Yang YX, Fan HN.
europepmc   +1 more source

An Innovative Immunotoxin Design Against Allergy Based on the IL-33 Cytokine and the Ribotoxin α-Sarcin. [PDF]

Int J Mol Sci
Narbona J, Lázaro-Gorines R, Gutiérrez-Carmona A, López-Rodríguez JC, Villalba M, Lacadena J.   +5 more
europepmc   +1 more source